Patents by Inventor Jens Habermann

Jens Habermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Platelet biomarkers in cancer diagnosis
    Patent number: 10054596
    Abstract: The present embodiments relate generally to the field of cancer diagnostics. More specifically the embodiments relate to platelet derived biomarkers used for diagnosis of cancer or cancer progression, as well as prognosis and improved treatment.
    Type: Grant
    Filed: January 22, 2014
    Date of Patent: August 21, 2018
    Assignee: NEOPROTEOMICS AB
    Inventors: Bo Franzèn, Gert Auer, Susanne Becker, Marta Lomnytska, Timo Gemoll, Jens Habermann
  • PLATELET BIOMARKERS IN CANCER DIAGNOSIS
    Publication number: 20150369817
    Abstract: The present embodiments relate generally to the field of cancer diagnostics. More specifically the embodiments relate to platelet derived biomarkers used for diagnosis of cancer or cancer progression, as well as prognosis and improved treatment.
    Type: Application
    Filed: January 22, 2014
    Publication date: December 24, 2015
    Inventors: Bo FRANZÈN, Gert AUER, Susanne BECKER, Marta LOMNYTSKA, Timo GEMOLL, Jens HABERMANN
  • Identification of biomarkers by serum protein profiling
    Patent number: 9075062
    Abstract: The present invention relates to methods of determining colorectal cancer status in a subject. The invention further relates to kits for determining colorectal cancer status in a subject. The invention further related to methods of identifying biomarker for determining colorectal cancer status in a subject.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: July 7, 2015
    Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
    Inventors: Thomas Ried, Jens Habermann
  • Gene expression signature of genomic instability in breast cancer
    Patent number: 8741574
    Abstract: Methods of assessing genomic instability in breast cancer tissue by measuring the expression level of genes CDKN2A, SCYA18, STK15, NXF1, cDNA Dkfzp762M127, p28 KIAA0882, MYB, Human clone 23948, RERG, HNF3A, and ACADSB or a nucleic acid sequence comprising about 90% or greater sequence identity to SEQ ID NO: 21 in breast cancer tissue, an array suitable for use in such methods, and related methods and compositions.
    Type: Grant
    Filed: September 15, 2009
    Date of Patent: June 3, 2014
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, West Virginia University Research Corporation
    Inventors: Karl Thomas Ried, Jens Habermann, Nancy Lan Guo, Gert Auer
  • DIFFERENTIAL DIAGNOSIS OF PANCREATIC ADENOMAS
    Publication number: 20130196876
    Abstract: The invention relates to a method for the diagnosis of pancreatic adenomas, to biomarkers for use in said method, to kits for carrying out the method, and to the use of said method for detecting pancreatic adenomas. The following markets are used: KCNABT, CIORF77, SPSB2, MED9, STK40, ITGB3BP, SCEL, PDPK1, DUSP15, MED19, NAP1L3, TMOD3, CSPP1, TMOD2, INPP5A and IGHG.
    Type: Application
    Filed: September 28, 2011
    Publication date: August 1, 2013
    Applicant: UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN
    Inventors: Jens Habermann, Timo Gemoll, Uwe Johannes Roblick
  • GENE EXPRESSION SIGNATURE OF GENOMIC INSTABILITY IN BREAST CANCER
    Publication number: 20110224089
    Abstract: Methods of assessing genomic instability in breast cancer tissue by measuring the expression level of genes CDKN2A, SCYA18, STK15, NXF1, cDNA Dkfzp762M127, p28 KIAA0882, MYB, Human clone 23948, RERG, HNF3A, and ACADSB or a nucleic acid sequence comprising about 90% or greater sequence identity to SEQ ID NO: 21 in breast cancer tissue, an array suitable for use in such methods, and related methods and compositions.
    Type: Application
    Filed: September 15, 2009
    Publication date: September 15, 2011
    Applicant: The United States of America, as represented by Secretary, Department of Health and Human Services
    Inventors: Karl Thomas Ried, Jens Habermann, Nancy Lan Guo, Gert Auer
  • Identification of Biomarkers by Serum Protein Profiling
    Publication number: 20090142332
    Abstract: The present invention relates to methods of determining colorectal cancer status in a subject. The invention further relates to kits for determining colorectal cancer status in a subject. The invention further related to methods of identifying biomarker for determining colorectal cancer status in a subject.
    Type: Application
    Filed: March 22, 2006
    Publication date: June 4, 2009
    Applicant: Government of the US, as represented by the Secretary, DHHS
    Inventors: Thomas Ried, Jens Habermann